This supposes that the rational for releasing a treatment is efficacy not life time profit. If it would be efficacy Ibogaine would be the standard of care for addiction, psylocibin for depression, MDMA for couple therapy and PTSD. Meanwhile it's the non working and dangerous SSRIs that are the standard of care.